Insulin price gouging shows Medicare should bargain for better drug prices
For patients with diabetes — particularly those with type 1 diabetes whose pancreases no longer produce the hormone insulin — [...]
Cap on drug price hikes for private health insurance sparks row in US
Workers and families with private health insurance would reap savings on prescription drugs from a little-noticed provision in President Joe [...]
Upper limit of drug price increase for the battle of sparks of private insurance
Washington – Workers and families with private health insurance will enjoy prescription drug savings from the lesser-known provisions of President [...]
Real Medicare drug savings in Dems’ bill — but not overnight
WASHINGTON, Medicare beneficiaries who use expensive medications could save thousands of dollars a calendar year under the Democrats' sweeping Social [...]
Pharmacovigilance and Drug Safety Software Market
Pharmacovigilance and Drug Safety Software Market Pharmacovigilance and Drug Safety Software Market to Grow at a CAGR of 7.6% to [...]
Health Economics & Outcomes Research (HEOR) Services Market Growth, Overview with Detailed Analysis 2021-2027| IQVIA, Pharmaceutical Product Development (PPD), Rti Health Solutions, UnitedHealth Group, and more
Health Economics & Outcomes Research (HEOR) Services Market Growth, Overview with Detailed Analysis 2021-2027| IQVIA, Pharmaceutical Product Development (PPD), RTI [...]
BridgeHead and Eclipse Advance Healthcare Integration with Clinical Trials
BridgeHead’s global partnership with Eclipse Clinical Technology brings together complementary solutions and services for the integration of healthcare data with [...]
Democrats say they are a party of science, but their drug pricing plans tell another story
New arrivalYou can now listen to Fox News articles. Democrats prefer to present themselves as a party of science, but [...]
The Best Opportunities for Marketers Within Telehealth
In April 2020, at the beginning of the pandemic, the use of telehealth surged with 32% of office and outpatient [...]
Cancer Patients May Get Faster and More Personalized Treatment as Result of Collaboration Between GE Healthcare, University of Cambridge and Addenbrooke’s Hospital – WorldNews
Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by [...]
Global Orphan Designated Drug Rare Disease Market Clinical Trials Development Report
NEW DELHI Global Orphan Drugs Clinical Trials Insight Report Highlights: Clinical Insight On More Than 400 Marketed Orphan Drugs Read [...]
Investing in Pharmaceutical Companies
In the life sciences sector, pharmaceutical companies work towards bringing new cures to the market and improving treatments available for [...]
Navigating the CURES Act and Patient Access Final Rules: 7 Key Insights for Payers
ZeOmega now provides a guide listing seven things payers need to understand to comply with the CURES Act Final Rule [...]
Will Rob Califf’s industry ties sink his FDA commissioner nomination?
Dr. Rob Califf’s extensive industry ties cast uncertainty on his nomination for FDA commissioner. The nominee’s financial disclosures, released this [...]
Deadline for ASHEcon 2022 extended to December 10th
The American Society of Health Economists (ASHEcon) has extended the deadline for abstracts at their 2022 meeting to December 10th, [...]
Call for Abstracts: ISPOR 2022
Session and abstract submissions are now open for ISPOR 2022, the preeminent health economics and outcomes research conference. ISPOR 2022 [...]
New Technology Adoption by Care Teams is Built on Trust
Providers' reticence to use new EHR technology is built on poor training and lack of trust, according to a new [...]
Navigating the FDA Real-Time Oncology Review Process for Sponsors
Started in 2018, the FDA’s “Real-Time Oncology Review (ROTR)” project gives sponsors a head start on the application review [...]
“Specialty Pharmacy’s Post-Pandemic Outlook” Asembia 2021 Keynote Recap
The future of specialty pharmacy in the post-pandemic world was the topic of the October 27th keynote sessions at Asembia [...]
Now Available: Economic & Related Consulting Service Revenues WORLD REPORT + DATABASE
Research and Markets has released their Economic & Related Consulting Service Revenues World Report + Database, which covers products and [...]
“The Power of Patient Advocacy” – Value & Outcomes Spotlight Seeks Submissions
ISPOR’s journal Value & Outcomes Spotlight welcomes submissions for its January/February 2022 issue, which is themed, “The Power of Patient [...]
ISPOR Signal Series: The New Science of Cause and Effect
The next ISPOR Signal series event will feature Judea Pearl, professor of computer science and director of the Cognitive Systems [...]
Role of Pharmacy Benefit Managers Under Congressional Scrutiny
The role of pharmacy benefit managers (PBM) on patient out of pocket prices was examined by a US congressional hearing [...]
Gene Therapy for Beta Thalassemia Gene Under ICER Assessment
A gene therapy for beta thalassemia will undergo ICER assessment for comparative clinical effectiveness and value. Betibeglogene autotemcel (Zynteglo/LentiGlobin) from [...]
Insurers Refuse to Pay for New Alzheimer’s Drug Without Evidence of Efficacy
Twenty-five major insurers will not pay for Biogen’s Alzheimer’s drug Aduhelm without further proof of efficacy, according to results from [...]